UCART19: First in Man Proof of Concept to be Presented at 2015 ASH Annual Meeting

First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL Gene Therapy and Transfer Program: Oral and Poster Abstracts Session: 801. Gene Therapy and Transfer: Poster I Saturday, December 5, 2015, 5:30 PM-7:30 PM Hall A, Level 2 (Orange County Convention Center) Waseem Qasim, MBBS PHD1*, Persis Jal Amrolia2*, Sujith Samarasinghe, MD, PhD3*, Sara Ghorashian, MD, PhD, FRCPath1*, Hong Zhan, PhD4*, Sian Stafford, PHD1*, Katie Butler, PHD1*, Gul Ahsan5*, Kimberly Gilmour5*, Stuart Adams, PHD5*, Danielle Pinner5*, Robert Chiesa5*, Steve Chatters, PHD5*, Sue Swift, PHD1*, Nicholas Goulden, MD, PhD3, Karl Peggs, MBBChir, MRCP, FRCPath6*, Adrian J Thrasher, MD, PhD1*, Paul Veys2* and Martin Pule, PhD7* 1 INSTITUTE OF CHILD HEALTH, UCL, London, United Kingdom 2 Bone Marrow Transplantation Department, Great Ormond Street Hospital, London, United Kingdom 3 Department of Haematology, Great Ormond Street Hospital For Children, London, United Kingdom 4 Institute of Child Health / Molecular and Cellular Immunology Unit, University College London, London, United Kingdom 5 GREAT ORMOND STREET HOSPITAL, London, United Kingdom 6 CANCER INSTITUTE, UCL, London, United Kingdom 7 Cancer Institute, University College London, London, United Kingdom

The release as fetched from its publisher. cellectis.com ↗